Cancer BiologybioRxivPreprint
Allosteric regulation of switch-II controls K-Ras oncogenicity
M. H. Yang, T. H. Tran, B. Hunt…·K. M. Haigis
This study shows that the K104Q mutation reduces oncogenic K-Ras activity in vivo by disrupting GEF-mediated nucleotide exchange and stabilizing switch-II helix through an allosteric network.
DOI 10.1101/2022.09.20.508702